Newly discovered angiogenesis inhibitors and their mechanisms of action
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.nature.com/articles/aps201297.pdf
Reference42 articles.
1. Zetter BR . The scientific contributions of M. Judah Folkman to cancer research. Nat Rev Cancer 2008; 8: 647–54.
2. Eichhorn ME, Kleespies A, Angele MK, Jauch KW, Bruns CJ . Angiogenesis in cancer: molecular mechanisms, clinical impact. Langenbecks Arch Surg 2007; 392: 371–9.
3. Fischer C, Mazzone M, Jonckx B, Carmeliet P . FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat Rev Cancer 2008; 8: 942–56.
4. Argyriou AA, Giannopoulou E, Kalofonos HP . Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas. Oncology 2009; 77: 1–11.
5. Tugues S, Koch S, Gualandi L, Li X, Claesson-Welsh L . Vascular endothelial growth factors and receptors: anti-angiogenic therapy in the treatment of cancer. Mol Aspects Med 2011; 32: 88–111.
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design, synthesis, and evaluation of antitumor activity in Pseudolaric acid B Azole derivatives: Novel and potent angiogenesis inhibitor via regulation of the PI3K/AKT and MAPK mediated HIF-1/VEGF signaling pathway;European Journal of Medicinal Chemistry;2024-11
2. Pseudolaric acid B induces apoptosis associated with the mitochondrial and PI3K/AKT/mTOR pathways in triple‑negative breast cancer;Oncology Reports;2023-09-14
3. Antitumor pharmacological research in the era of personalized medicine;Acta Pharmacologica Sinica;2022-11-24
4. DHPAC, a novel microtubule depolymerizing agent, suppresses angiogenesis and vasculogenic mimicry formation of human non‐small cell lung cancer;Journal of Cellular Biochemistry;2020-02-14
5. Glucocerebroside reduces endothelial progenitor cell-induced angiogenesis;Food and Agricultural Immunology;2019-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3